Clin2
NCT06701760Possibly a fitNot yet recruiting

Testing a salt solution for severe traumatic brain injury

Traumatic Brain Injury

Treatments studied

Part of Brain & nervous system, Injuries & trauma clinical trials.

This trial tests giving a simple salt solution (sodium lactate) to people with severe traumatic brain injury. The goal is to see if it can reduce swelling and improve recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
264 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You must be between 18 and 80 years old.
  • You must have a severe traumatic brain injury (Glasgow Coma Scale score of 3-8) and a CT scan showing brain damage.
  • You must not have other serious injuries or conditions like severe bleeding, kidney problems, or high blood acid levels.
  • You must not have a history of neurological diseases (like Parkinson's or Alzheimer's) or diabetes.
  • You must not have a known mitochondrial genetic disorder.
  • You or your legal representative must give written permission to join the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04602806Enrolling by invitation
Precision medicine study for traumatic brain injury

This study is looking at people with traumatic brain injuries to improve how they are treated. If you join, you will get an MRI and other tests within the first two days after your injury, and the researchers will track your recovery over time.

San Francisco, California
NCT06966713Recruiting
Predicting recovery after severe brain injury

This study looks at patients with severe traumatic brain injury (TBI) who already need brain pressure or oxygen monitoring. Doctors want to see if certain tests can help predict how well someone might recover.

Chicago, Illinois
NCT06282965Recruiting· Phase 1/Phase 2
Angiotensin (1-7) for moderate to severe brain injury

This study tests a drug called Angiotensin (1-7) to see if it helps people recover from moderate to severe traumatic brain injury. It may reduce damage and improve healing when given shortly after the injury.

Tucson, Arizona
NCT06790095Enrolling by invitation· Phase 2
Testing Cyclosporine for Moderate to Severe Brain Injury

This study tests a drug called cyclosporine to see if it can help people with moderate to severe traumatic brain injury. You may be eligible if you have a brain injury seen on CT and can start treatment within 24 hours.

San Francisco, California
NCT06866691Recruiting· Phase 4
Seizure prevention after traumatic brain injury

This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.

Winston-Salem, North Carolina
NCT07625995Recruiting· Phase 2
Fluid management strategies for traumatic brain injury patients

This study tests two different approaches to managing fluids given to brain injury patients in the ICU—one more restrictive and one more liberal—to see which is safer and more effective. The goal is to find the best balance that protects the brain while supporting overall health.

Brussels

Hear when a new Traumatic Brain Injury trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.